Increasing optical content in AI networks will sustain supplier demand and margin gains through the next two reporting cycles, before added capacity or substitution removes the advantage.

Why now

Lumentum and Coherent provide current issuer evidence of demand and product progress; Coherent also reports expanding capacity, making supply response an immediate test.

In scope

Commercial optical links, lasers, modules, switching and related interconnect economics · Supplier capacity, qualifications, orders and margins

Out of scope

Assuming every AI supplier shares the same shortage · Pre-commercial technologies without customer revenue · Rack power conversion except as shared context

Expected horizon

6–18 months; the shared test with the AI-spending counter-case runs through March 2027.

What supports it

Orders and optical revenue convert alongside stable or improving margins · Customer demand absorbs new capacity without broad price concessions

What would break it

Capacity relief or substitution causes order weakness and margin deterioration across two supplier reports · By March 2027, spending cuts reverse demand and margin gains at both core optical suppliers

Next review 2026-11-02 · Fabrinet's report, provider-estimated for November 2 (observed August 18), opens the two-report failure test; Coherent follows on November 4 after the close (company's investor-relations page) and Lumentum on November 5 (provider calendar). Read orders, delivered optical revenue, gross margin, pricing, capacity adds and any co-packaged-optics or substitution comment; keep management guidance separate from delivered results. Review earlier if an issuer confirms Thai flood disruption, or on a primary (issuer release, filing or call transcript) allocation, ramp, cancellation or capacity update. The capacity clause has already fired on secondary reports: Lumentum's CEO saying capacity is sold out through early 2029 (Bloomberg, relayed on X October 8-9) and that 2027 supply covers about 30% of demand (forum remarks transcribed on X, October 2), reviewed October 16 as guidance rather than delivered results; further restatements of the same claim are not a trigger.